A quick update on drug safety: today, the FDA announced that it is testing and reviewing the drug Heparin following the possibly related death of two Delaware patients last week, sparking new concerns of Heparin contamination. Though the 2008 contamination was linked to Chinese-based products, the drug was found responsible for more than eighty deaths. Will these two deaths - and third illness, also in Delaware - be enough to conduct a full review of the safety and efficacy of drug production and process? The FDA has remained quiet on the issue, stating only that this incident appears to be isolated. We're not so sure, and will stay up-to-date on the FDA investigation and conclusions.